Amlylin Pharma (AMLN): Upgraded to Buy at Citigroup; Street high target of $27
Tweet Send to a Friend
From Notable Calls
Amylin Pharma (NASDAQ: AMLN) is getting lots of very positive commentary this morning after the FDA issued ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Amylin Pharma (NASDAQ: AMLN) is getting lots of very positive commentary this morning after the FDA issued ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
